Christopher Watt
Keine laufenden Positionen mehr
Profil
Christopher Watt worked as a Senior Vice President-Finance at Tetraphase Pharmaceuticals, Inc. from 2017 to 2020 and as a Vice President-Finance at Biogen, Inc. from 2015 to 2017.
Prior to that, he earned an MBA from the University of Michigan and an undergraduate degree from Colby College.
Ehemalige bekannte Positionen von Christopher Watt
| Unternehmen | Position | Ende |
|---|---|---|
| TETRAPHASE PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 28.07.2020 |
| BIOGEN INC. | Corporate Officer/Principal | 01.07.2015 |
Ausbildung von Christopher Watt
| Colby College | Undergraduate Degree |
| University of Michigan | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BIOGEN INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetraphase Pharmaceuticals, Inc. is engaged in the development and production of novel tetracyclines for serious and life-threatening bacterial infections. It also develops eravacycline, a synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Waltham, MA. | Health Technology |
